Related Experiment Videos
[Tenosynovial giant cell tumor]
C Kuhnen1, K-M Müller, S Rabstein
1Institut für Pathologie, Register für Gliedmassentumoren, Berufsgenossenschaftliche Kliniken Bergmannsheil, Ruhr-Universität Bochum. Cornelius.Kuhnen@ruhr-uni-bochum.de
Der Pathologe
|January 20, 2005
Summary
Diffuse-type tenosynovial giant cell tumors exhibit unique vascular patterns and hemosiderosis. These findings differentiate them from localized types, aiding in diagnosis.
Area of Science:
- Pathology
- Histology
- Immunohistochemistry
Context:
- Tenosynovial giant cell tumors (TGCT) present in localized and diffuse forms.
- Distinguishing between these subtypes is crucial for accurate diagnosis and treatment.
Purpose:
- To compare the morphological, ultrastructural, and immunohistochemical features of diffuse-type TGCT (pigmented villonodular synovitis) with localized-type TGCT (giant cell tumor of tendon sheath).
Summary:
- Diffuse-type TGCT shows distinct vascularization with abnormal small blood vessels and significant hemosiderosis, likely due to tumor cell-induced vessel compression.
- Microhemorrhagic foci and multinucleated giant cells are common in both types, but diffuse-type exhibits unique "giant" hemosiderotic granules and pseudoalveolar clefts.
- Immunohistochemistry revealed focal CD31 and calretinin expression in diffuse-type TGCT, alongside the expected CD68 staining.
Impact:
- These findings enhance the understanding of diffuse-type TGCT pathogenesis and provide diagnostic criteria for differentiating it from localized-type TGCT.
- The study contributes to improved diagnostic accuracy for pigmented villonodular synovitis and giant cell tumors of tendon sheath.